Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01288560 · ClinicalTrials.gov registry record · NA
IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF)
A NA study, sponsored by Ottawa Heart Institute Research Corporation.
- Completed
- Registry status
- NA
- Development phase
- 1,390
- Enrollment target
NCT01288560 is a NA study that has completed, run by Ottawa Heart Institute Research Corporation. The registered enrollment target is 1,390 participants.
The verdict
NCT01288560, a NA study, has completed, sponsored by Ottawa Heart Institute Research Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,390 participants
- Enrollment target
Study Summary
Medical imaging is one of the fastest growing sectors in health care and increases in utilization underscore the need to ensure imaging technology is developed and used effectively. Evaluation of the clinical and economic impact of such imaging lags behind the technology development. Heart failure (HF) represents the final common pathway for most forms of heart disease and morbidity and mortality remain high. There is a need to identify imaging approaches that have a positive impact on therapy decisions, patient outcomes and costs. As well as standard methods to evaluate new and emerging techniques to better test their potential in a clinical management setting. PRIMARY OBJECTIVES: to compare the effect of HF imaging strategies on the composite clinical endpoint of cardiac death, MI, resuscitated cardiac arrest and cardiac re-hospitalization (WHF, ACS, arrhythmia). Patients with an ischemic heart disease (IHD) etiology will follow HF imaging strategy algorithms according to the question(s) asked by the physicians (is there ischemia and/or viability), in agreement with their local practices for standard and alternative imaging. SECONDARY OBJECTIVES: 1. To evaluate the effect of imaging modalities within and between the imaging subgroups (advanced (CMR and PET), PET, MRI and standard (SPECT)) on the primary and secondary outcomes in patients being evaluated either for viability and/or ischemia. 2. To evaluate the impact of adherence to recommendations between modalities on outcomes in patients being evaluated for either viability or ischemia. 3. To compare the effect of HF imaging strategies on: 1. The incidence of revascularization procedures (PCI, CABG, none) and the interaction of the imaging strategy and types of revascularization on outcomes 2. LV remodeling: LV volumes, LVEF, 3. HF symptoms, NYHA class 4. QOL (MLHFQ, the EQ5D) 5. The evolution of serum prognostic markers in HF (e.g. BNP, RDW, hs-cTnT, hs-CRP, ST2) 6. Health economics: Costs
Interventions
- OTHER Advanced cardiac imaging
- OTHER Standard Cardiac Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,390 participants |
| Start Date | 2011-01 |
| Est. Completion | 2022-10-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01288560
The ClinicalTrials.gov registry entry for NCT01288560 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,390 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ottawa Heart Institute Research Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Advanced cardiac imaging is the first listed.
NCT01288560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01288560 about?
NCT01288560 is a clinical study titled "IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF)". Medical imaging is one of the fastest growing sectors in health care and increases in utilization underscore the need to ensure imaging technology is developed and used effectively. Evaluation of the clinical and economic impact of such imaging lags behind the technology development. Heart failure (...
What is the current status of trial NCT01288560?
This trial is currently completed. It is a NA study. The enrollment target is 1,390 participants. The study started on 2011-01. Estimated completion is 2022-10-04.
What interventions are being tested in trial NCT01288560?
The interventions under investigation include: Advanced cardiac imaging (OTHER), Standard Cardiac Imaging (OTHER).
Who is sponsoring clinical trial NCT01288560?
This trial is sponsored by Ottawa Heart Institute Research Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.